ArcherDX

Website:archerdx.com
Location:Boulder, CO United States
Revenue:$36.3M
Industry:Biotech
Founded:2013
Lead Investor(s):Boulder Ventures, Ltd., PBM Capital Group, LLC
Press

Current Growjo Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

ArcherDX, Inc., creates catalog and custom next-generation sequencing (NGS) assays that are purpose-built to identify mutations and gene fusions from clinical sample types. By combining novel enrichment chemistry, automated informatics and a user-friendly workflow, Archer? products remove the bottlenecks associated with using next-gen sequencing in a translational setting.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals

145

Number of Employees

$36.3M

Revenue (est)

29

Current Jobs

44%

Employee Growth %

$35M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

ArcherDX News

15-Feb-19 - ArcherDX Enters Newborn Screening Market with Baby Genes

ArcherDX is expanding its product portfolio with newborn and screening tests to identify carriers of genetic variants linked to different disorders,

5-Mar-19 - ArcherDX Announces Expansion of Executive Leadership Team as

BOULDER, Colo., March 5, 2019 /PRNewswire/ -- ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough

14-Feb-19 - ArcherDX announces strategic collaboration with Genosity

ArcherDX, a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalised

ArcherDX Funding

DateAmountRoundLead InvestorsReference
2018-03-21$35.0MABoulder Ventures, Ltd.Article

ArcherDX Acquisitions

DateCompany NameAmountNotesReference
2019-01-31Baby Genes, IncArticle